340 related articles for article (PubMed ID: 27813051)
1. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
[TBL] [Abstract][Full Text] [Related]
2. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS
Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
[TBL] [Abstract][Full Text] [Related]
3. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
Smans L; Lentjes E; Hermus A; Zelissen P
Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
[TBL] [Abstract][Full Text] [Related]
4. Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease.
Methlie P; Husebye EE; Hustad S; Lien EA; Løvås K
Eur J Endocrinol; 2011 Nov; 165(5):761-9. PubMed ID: 21896619
[TBL] [Abstract][Full Text] [Related]
5. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
Løvås K; Thorsen TE; Husebye ES
J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
[TBL] [Abstract][Full Text] [Related]
6. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
[TBL] [Abstract][Full Text] [Related]
7. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles.
Ekman B; Blomgren J; Andersson PO; Carlsson M; Arnqvist HJ
Horm Metab Res; 2010 Dec; 42(13):961-6. PubMed ID: 20925018
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
[TBL] [Abstract][Full Text] [Related]
9. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone.
Meulenberg PM; Ross HA; Swinkels LM; Benraad TJ
Clin Chim Acta; 1987 Jun; 165(2-3):379-85. PubMed ID: 3652459
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
Fichna M; Gryczyńska M; Sowińska A; Sowiński J
Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
[TBL] [Abstract][Full Text] [Related]
11. Reference ranges of late-night salivary cortisol and cortisone measured by LC-MS/MS and accuracy for the diagnosis of Cushing's syndrome.
Ponzetto F; Settanni F; Parasiliti-Caprino M; Rumbolo F; Nonnato A; Ricciardo M; Amante E; Priolo G; Vitali S; Anfossi L; Arvat E; Ghigo E; Giordano R; Mengozzi G
J Endocrinol Invest; 2020 Dec; 43(12):1797-1806. PubMed ID: 32772255
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
13. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
Thomson AH; Devers MC; Wallace AM; Grant D; Campbell K; Freel M; Connell JM
Clin Endocrinol (Oxf); 2007 Jun; 66(6):789-96. PubMed ID: 17437510
[TBL] [Abstract][Full Text] [Related]
14. Salivary cortisol and cortisone in the clinical setting.
Blair J; Adaway J; Keevil B; Ross R
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):161-168. PubMed ID: 28375882
[TBL] [Abstract][Full Text] [Related]
15. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
[TBL] [Abstract][Full Text] [Related]
16. Salivary cortisol and cortisone responses to tetracosactrin (synacthen).
Cornes MP; Ashby HL; Khalid Y; Buch HN; Ford C; Gama R
Ann Clin Biochem; 2015 Sep; 52(Pt 5):606-10. PubMed ID: 25724424
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis suppression - The value of salivary cortisol and cortisone in assessing hypothalamic-pituitary-adrenal recovery.
Kalaria T; Agarwal M; Kaur S; Hughes L; Sharrod-Cole H; Chaudhari R; Gherman-Ciolac C; Chopra R; Okeke V; Ford C; Buch H; Gama R
Ann Clin Biochem; 2020 Nov; 57(6):456-460. PubMed ID: 32961064
[TBL] [Abstract][Full Text] [Related]
18. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
[TBL] [Abstract][Full Text] [Related]
19. Measurement of Salivary Cortisone to Assess the Adequacy of Hydrocortisone Replacement.
Raff H
J Clin Endocrinol Metab; 2016 Apr; 101(4):1350-2. PubMed ID: 26990943
[TBL] [Abstract][Full Text] [Related]
20. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
Aanderud S; Myking OL; Bassøe HH
Acta Endocrinol (Copenh); 1982 Aug; 100(4):588-94. PubMed ID: 6289586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
